The five-year effects of testosterone replacement therapy on lipid profile and glucose tolerance among hypogonadal men in Japan: a case control study
- 2 January 2019
- journal article
- research article
- Published by Taylor & Francis in The Aging Male
- Vol. 23 (1) , 23-28
Abstract
Objective: This study investigated the efficacy of 5-year testosterone replacement therapy (TRT) on lipid profile and glucose tolerance in Japanese hypogonadal men. Methods: Fourteen patients, who received continuous TRT for 5 years, and 22 controls with 5-year observations were enrolled. The patients in the TRT group had received intramuscular injections of testosterone enanthate (250 mg) every month for 5 years. We collected the following data: blood pressure, fasting blood sugar (FBS), hemoglobin A1c (HbA1c), total cholesterol, triglyceride (TG), high density lipoprotein-Chol values, and prostate specific antigen (PSA) level at baseline, 1-, 3-, and 5-years from initial intervention. These data were compared between the two groups. Results: There were no statistically significant differences in any other baseline characteristic, excluding SBP, between the two groups. FBS was significantly improved at 3- and 5-year visits in the TRT group compared to the control group. Furthermore, the HbA1c level and TG value demonstrated a significant decrease at 1-, 3-, and 5-years in the TRT group. However, no significant difference in changes to PSA levels from baseline in both groups was observed. Conclusions: Five-year TRT could improve FBS, HbA1c, and TG levels among Japanese hypogonadal men with no significant increase in PSA.Keywords
This publication has 20 references indexed in Scilit:
- Effects of long-term androgen replacement therapy on the physical and mental statuses of aging males with late-onset hypogonadism: a multicenter randomized controlled trial in Japan (EARTH Study)Asian Journal of Andrology, 2016
- Effects of Five-Year Treatment with Testosterone Undecanoate on Metabolic and Hormonal Parameters in Ageing Men with Metabolic SyndromeInternational Journal of Endocrinology, 2014
- Long‐term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long‐term registry studyInternational Journal Of Clinical Practice, 2013
- How to help the aging male? Current approaches to hypogonadism in primary careThe Aging Male, 2012
- Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled studyThe Aging Male, 2010
- Testosterone replacement therapy by testosterone ointment relieves lower urinary tract symptoms in late onset hypogonadism patientsThe Aging Male, 2010
- Hypogonadotrophic hypogonadism in type 2 diabetesThe Aging Male, 2008
- The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadismThe Aging Male, 2008
- Investigation, treatment and monitoring of late-onset hypogonadism in males.Official Recommendations of ISSAMThe Aging Male, 2002
- Low serum testosterone level as a predictor of increased visceral fat in Japanese-American menInternational Journal of Obesity, 2000